No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
TBPH Theravance Biopharma
- 9.720
- +0.620+6.81%
Close Mar 5 16:00 ET
- 9.720
- 0.0000.00%
Post 16:13 ET
481.14MMarket Cap-8.45P/E (TTM)
9.800High9.070Low344.91KVolume9.140Open9.100Pre Close3.30MTurnover1.61%Turnover RatioLossP/E (Static)49.50MShares10.90052wk High2.72P/B208.51MFloat Cap7.44052wk Low--Dividend TTM21.45MShs Float124.866Historical High--Div YieldTTM8.02%Amplitude6.100Historical Low9.579Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Theravance's Q4 Loss In Line With Estimates, Sales Beat
TD Cowen Maintains Theravance Biopharma(TBPH.US) With Hold Rating, Raises Target Price to $12
Earnings Call Summary | Theravance Biopharma(TBPH.US) Q4 2024 Earnings Conference
Theravance Biopharma Q4 Adj EPS $(0.05) Beats $(0.21) Estimate, Sales $18.75M Beat $17.09M Estimate
Theravance Biopharma GAAP EPS of -$0.31 Misses by $0.11, Revenue of $18.75M Beats by $1.66M
Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results
Trending Stocks
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.
Log In for the Full List
Unlock Now